Download presentation
Presentation is loading. Please wait.
Published byTeguh Budiono Modified over 6 years ago
1
New Therapies for Hyperkalemia Across the Continuum of Care
3
Overview of Hyperkalemia
4
RAAS Inhibitor Use and Risk of Hyperkalemia
5
Diagnostic Workup Causes of Hyperkalemia
6
Diagnostic Workup Electrocardiographic Features
7
Acute Treatment of Hyperkalemia
8
Increasing Incidence of Hyperkalemia
9
Dietary Management of Hyperkalemia
10
Management of Chronic Hyperkalemia Before Era of New K+ Binders
11
SPS
12
Challenges of Hyperkalemia in At-Risk Patients
13
Summary
14
New K+ Binder Patiromer
15
Efficacy of Patiromer Maintains Normal K+ Levels Up to 1 Year
16
Emerging K+ Binder Sodium Zirconium Cyclosilicate (ZS-9)
17
Efficacy of ZS-9 During 48-h Induction Phase in HARMONIZE
18
HARMONIZE Efficacy During Randomized Phase
19
ZS005 Interim Results ZS-9 Maintains Normal K+ Levels Up to 1 Year
20
K+ and Na+ Concentrations in the GI Tract
21
SPS (cont)
22
SPS Plus Sorbitol vs Sorbitol Alone
23
New K+ Binders Adverse Events
24
Comparison of SPS, Patiromer, and ZS-9
25
New K+ Binders as Preventative Therapy
26
Closing Comments
27
Abbreviations
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.